<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<title>AI-Powered Breast Cancer Therapy Optimizer</title>
<style>
  body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: #f5f9fc;
    color: #222;
    margin: 0;
    padding: 0 1rem;
  }
  header {
    text-align: center;
    padding: 2rem 0 1rem;
  }
  h1 {
    color: #004b87;
  }
  main {
    max-width: 700px;
    margin: 0 auto 3rem;
    background: #fff;
    border-radius: 8px;
    box-shadow: 0 0 12px rgba(0,0,0,0.1);
    padding: 2rem;
  }
  section {
    margin-bottom: 2rem;
  }
  label {
    font-weight: 600;
  }
  select {
    font-size: 1rem;
    padding: 0.5rem;
    margin-top: 0.5rem;
    width: 100%;
    max-width: 300px;
  }
  button {
    background: #0077cc;
    color: white;
    border: none;
    border-radius: 5px;
    padding: 0.75rem 1.5rem;
    font-size: 1rem;
    cursor: pointer;
    margin-top: 1rem;
    transition: background-color 0.3s ease;
  }
  button:hover {
    background: #005fa3;
  }
  .result {
    background: #e1f0ff;
    padding: 1.5rem;
    border-radius: 6px;
    font-size: 1.1rem;
    line-height: 1.5;
  }
  a {
    color: #0077cc;
    text-decoration: none;
  }
  a:hover {
    text-decoration: underline;
  }
  footer {
    text-align: center;
    color: #666;
    font-size: 0.9rem;
    margin-bottom: 1rem;
  }
</style>
</head>
<body>
<header>
  <h1>AI-Powered Breast Cancer Therapy Optimizer</h1>
  <p>Using deep learning and genomic biomarkers to personalize breast cancer treatment</p>
</header>
<main>
  <section>
    <h2>About the model</h2>
    <p>
      Every year, millions of women face breast cancer. Choosing the right therapy is complex and depends on tumor biology, genetics, and patient history. Our Deep Q-Learning model, trained on The Cancer Genome Atlas data, simulates multiple treatment options and predicts the most effective and least toxic plan for each patient — empowering oncologists and improving outcomes.
    </p>
    <p><strong>Key results from the study:</strong></p>
    <ul>
      <li>Average tumor reduction: 129.71 mm</li>
      <li>Minimum tumor reduction: 95.01 mm</li>
      <li>Maximum tumor reduction (complete elimination): 150.0 mm</li>
      <li>Side effects score below 0.0802</li>
      <li>Genetic differentiation for markers TP53, KRAS, BRAF ranging from 9.53 to 12.96</li>
    </ul>
  </section>

  <section>
    <h2>Try it yourself</h2>
    <label for="marker">Select a key genetic marker:</label>
    <select id="marker">
      <option value="">--Choose a marker--</option>
      <option value="TP53">TP53</option>
      <option value="KRAS">KRAS</option>
      <option value="BRAF">BRAF</option>
    </select>
    <button onclick="showResult()">Show optimized therapy recommendation</button>

    <div id="result" class="result" style="display:none;"></div>
  </section>

  <section>
    <h2>Full scientific preprint</h2>
    <p>
      Read the full study here: <a href="https://www.researchgate.net/publication/391777596_Personalized_Breast_Cancer_Therapy_Optimization_Using_Deep_Q-Learning_and_TCGA_Data" target="_blank" rel="noopener noreferrer">AI-Powered Breast Cancer Therapy Optimization (Preprint)</a>
    </p>
  </section>
</main>

<footer>
  Created for @karpathy's #PayoutChallenge — August 2025
</footer>

<script>
  const recommendations = {
    TP53: {
      tumorReduction: "130 mm (average)",
      sideEffects: "Below 0.08",
      therapy: "Targeted chemotherapy with personalized dose adjustment",
      description: "For patients with TP53 mutations, the model recommends a targeted chemotherapy approach optimized for efficacy and minimal side effects."
    },
    KRAS: {
      tumorReduction: "125 mm (average)",
      sideEffects: "Below 0.08",
      therapy: "Combination of hormonal and immunotherapy agents",
      description: "Patients with KRAS mutations benefit from a combination therapy designed to reduce tumor size effectively while managing side effects."
    },
    BRAF: {
      tumorReduction: "128 mm (average)",
      sideEffects: "Below 0.08",
      therapy: "Personalized targeted inhibitors combined with low-dose chemotherapy",
      description: "The model suggests personalized targeted inhibitors tailored to BRAF marker presence, enhancing tumor reduction."
    }
  };

  function showResult() {
    const marker = document.getElementById('marker').value;
    const resultDiv = document.getElementById('result');

    if (!marker) {
      resultDiv.style.display = 'none';
      alert('Please select a genetic marker to see the therapy recommendation.');
      return;
    }

    const rec = recommendations[marker];
    resultDiv.style.display = 'block';
    resultDiv.innerHTML = `
      <strong>Genetic Marker:</strong> ${marker}<br/>
      <strong>Expected Tumor Reduction:</strong> ${rec.tumorReduction}<br/>
      <strong>Side Effects Score:</strong> ${rec.sideEffects}<br/>
      <strong>Recommended Therapy:</strong> ${rec.therapy}<br/>
      <p>${rec.description}</p>
    `;
  }
</script>
</body>
</html>
